Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Indikator
Negara-negara
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Pendapatan
Liburan
Negara-negara
Amerika Serikat
Inggris Raya
Kawasan Euro
Australia
Kanada
Jepang
Tiongkok
Brazil
Rusia
India
Selanjutnya Negara-negara
Indikator
Suku Bunga
Tingkat Inflasi
Tingkat Pengangguran
Pertumbuhan PDB (q-to-q)
Pdb Per Kapita
Transaksi Berjalan
Cadangan Emas
Utang Pemerintah
Produksi Minyak Mentah
Harga Bensin
Peringkat Kredit
Selanjutnya Indikator
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Apps
App Store
Google Play
Twitter
Akebia Therapeutics | AKBA - Aset Lancar
Keuangan
Harga Saham
USD
Aktiva
USD 376.57M
Kas Dan Setara
USD 184.84M
Biaya Penjualan
USD 10.34M
Aset Lancar
USD 252.96M
Kewajiban Lancar
USD 162.94M
UTANG
USD 46.51M
Dividen - Hasil
0
EBIT
USD -5.45M
EBITDA
USD 14.03M
Karyawan
167
Eps Laba Per Saham
USD -0.04
Modal Dan Cadangan
USD 32.61M
Laba Kotor Pada Penjualan
USD 47.28M
Beban Bunga Utang
4.83M
Modal Pinjaman
USD 48.25M
Kapitalisasi Pasar
USD 316M
Batas Pemasukan
USD -12.24M
Biaya Operasional
USD 63.08M
Laba Operasional
USD -5.45M
Modal Saham Biasa
USD 265.43M
Pe Harga Untuk Laba
1.63K
Laba Sebelum Pajak
USD -11.24M
Pendapatan Penjualan
USD 57.62M
Beban Penjualan Dan Administrasi
USD 23.53M
Saham
USD 15.61M
Kreditur Perdagangan
USD 21.19M
Debitur Perdagangan
USD 47.03M
Aset Lancar
Perubahan
Tanggal
Acadia Pharmaceuticals
USD 1.06B
14.31M
2025-12
Agios Pharmaceuticals
USD 834.84M
107.21M
2026-03
Akebia Therapeutics
USD 252.96M
5.38M
2025-12
Alnylam Pharmaceuticals
USD 4.22B
168.65M
2026-03
Amgen
USD 31.48B
2.42B
2026-03
Ardelyx
USD 381.87M
447K
2026-03
Astellas Pharma
JPY 1.42T
19.35B
2026-03
AstraZeneca
USD 29.61B
890M
2026-03
Bayer
EUR 32.91B
30M
2025-12
BioMarin Pharmaceutical
USD 4.61B
651.58M
2026-03
Celltrion
KRW 5.54T
291.68B
2025-09
Cspc Pharmaceutical
CNY 22.25B
359.48M
2025-12
Deva Holding AS
TRY 9.13B
1.61B
2023-09
Dianthus Therapeutics
USD 1.12B
710.47M
2026-03
Exelixis
USD 1.44B
41.03M
2025-12
Fresenius Medical Care
EUR 7.9B
74M
2025-12
GlaxoSmithKline
GBP 17.76B
251M
2026-03
Ionis Pharmaceuticals
USD 2.94B
52M
2026-03
Ironwood Pharmaceuticals
USD 273.84M
82.09M
2025-09
J&J
USD 59.17B
3.55B
2026-03
Kangmei Pharma
CNY 7.03B
128.34M
2025-09
Karyopharm Therapeutics
USD 103.15M
13.4M
2025-12
Knight Therapeutics
CAD 394.84M
5.86M
2025-12
Laboratorios Farma
EUR 509.33M
128.63M
2023-12
Lexicon Pharmaceuticals
USD 101.9M
20.63M
2025-12
Malin Corporation
EUR 62.6M
26.7M
2024-12
Medical Developments International
AUD 33.75M
1.79M
2025-12
Moderna
USD 5.77B
774M
2026-03
Nektar Therapeutics
USD 266.27M
15.09M
2025-12
Neuren Pharmaceuticals
AUD 332.23M
11.98M
2025-12
Organigram Holdings
CAD 256.54M
28.35M
2025-12
Ovoca Bio
EUR 1.56M
3.39M
2025-06
Pharma Mar
EUR 273.45M
9.96M
2026-03
Prothena
USD 315.19M
24.78M
2025-12
PTC Therapeutics
USD 2.27B
266.14M
2025-12
Qiagen NV
USD 2B
535.87M
2025-12
Regeneron Pharmaceuticals
USD 18.21B
187.3M
2026-03
Roche Holding
CHF 38.73B
3.03B
2025-12
Sanofi
EUR 30.16B
789M
2026-03
Sarepta Therapeutics
USD 2.54B
184.37M
2025-12
Sartorius
EUR 1.92B
157.2M
2026-03
Sino Biopharmaceutical
CNY 33.82B
9.13B
2025-06
Tectonic Therapeutic
USD 257.36M
15.88M
2025-12
Tilray
USD 729.32M
28.18M
2025-09
Vanda Pharmaceuticals
USD 347.26M
20.23M
2025-12
Zealand Pharma A/S
15.67B
950.94M
2025-12
Zz Pientze Pharmaceu
CNY 11.43B
728.95M
2026-03
×